BSX vs TRS · P/E 20, rev $10.65B vs P/E 122, rev $342.9M
Boston Scientific Corp (BSX) versus TriMas Corporation (TRS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
TriMas Corporation (TRS) is a packaging & containers company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported TRS revenue for 2026-06-30 was $342.9M. Net income was $814.2M. TRS currently screens at market cap $1.53B and trailing P/E 121.8.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. TRS currently screens at market cap $1.53B and trailing P/E 121.8.
Not investment advice. Open the BSX and TRS stock pages for the full models.
Not investment advice.